Fund holdings
1.7MShares reported · +972K vs prior quarter
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Loading…
VTRS · NASDAQ · Pharmaceuticals
From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
A Schedule 13G is filed by holders above 5% who say they will not try to influence the company. Index funds and large asset managers file most of them.
Institutions reporting a stake, Q2 2026
1,020
-3 vs Q1 2026
Share of stock reported
91.5%
1.05B of 1.15B shares outstanding
Change vs Q1 2026
+57.2M shares
93 new positions, 95 positions closed
Reported in 13F filings, which cover managers over $100M and include double counting. A 13F shows holdings on the last day of the quarter, not when shares were bought or sold. Change counts the 999 managers that reported both quarters.
Source: SEC Form 13F data sets, every filer, common stock only (options and bonds left out); 13 managers also reported puts and 19 managers calls. Amendments are applied; lines whose value was filed in thousands are scaled, and lines whose shares and value disagree are left out.